EDOC vs. IBB
EDOC (Global X Telemedicine & Digital Health ETF) and IBB (iShares Nasdaq Biotechnology ETF) are both Health & Biotech Equities funds - EDOC tracks the Solactive Telemedicine & Digital Health Index- TR Net while IBB tracks the NASDAQ Biotechnology Index. Both are passively managed. Over the past 5 years, EDOC returned -14.64%/yr vs 2.21%/yr for IBB. A 0.70 correlation means they provide meaningful diversification when combined. EDOC charges 0.68%/yr vs 0.47%/yr for IBB.
Performance
EDOC vs. IBB - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, EDOC achieves a -10.37% return, which is significantly lower than IBB's 5.61% return.
EDOC
- 1D
- 1.49%
- 1M
- 5.54%
- YTD
- -10.37%
- 6M
- -12.67%
- 1Y
- -16.13%
- 3Y*
- -8.12%
- 5Y*
- -14.64%
- 10Y*
- —
IBB
- 1D
- 0.62%
- 1M
- 5.52%
- YTD
- 5.61%
- 6M
- 3.57%
- 1Y
- 42.90%
- 3Y*
- 11.80%
- 5Y*
- 2.21%
- 10Y*
- 8.21%
EDOC vs. IBB - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
EDOC Global X Telemedicine & Digital Health ETF | -10.37% | -0.62% | -2.87% | -12.61% | -29.99% | -14.21% | 16.89% |
IBB iShares Nasdaq Biotechnology ETF | 5.61% | 27.98% | -2.41% | 3.76% | -13.69% | 0.95% | 10.98% |
Correlation
The correlation between EDOC and IBB is 0.54, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.54 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.60 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.69 |
Correlation (All Time) Calculated using the full available price history since Jul 30, 2020 | 0.70 |
The correlation between EDOC and IBB shifts across timeframes, from 0.54 (1 year) to 0.70 (all time), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
EDOC vs. IBB — Risk / Return Rank
EDOC
IBB
EDOC vs. IBB - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Global X Telemedicine & Digital Health ETF (EDOC) and iShares Nasdaq Biotechnology ETF (IBB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| EDOC | IBB | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.85 | ||
| Sortino ratioReturn per unit of downside risk | -3.91 | ||
| Omega ratioGain probability vs. loss probability | 0.90 | 1.35 | -0.45 |
| Calmar ratioReturn relative to maximum drawdown | -0.53 | 4.47 | -5.00 |
| Martin ratioReturn relative to average drawdown | -1.01 | 13.77 | -14.78 |
Loading charts...
Drawdowns
EDOC vs. IBB - Drawdown Comparison
The maximum EDOC drawdown since its inception was -65.76%, roughly equal to the maximum IBB drawdown of -62.85%. Use the drawdown chart below to compare losses from any high point for EDOC and IBB.
Loading charts...
Drawdown Indicators
| EDOC | IBB | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -65.76% | -62.85% | -2.91% |
Max Drawdown (1Y)Largest decline over 1 year | -30.71% | -9.63% | -21.08% |
Max Drawdown (3Y)Largest decline over 3 years | -35.78% | -24.85% | -10.93% |
Max Drawdown (5Y)Largest decline over 5 years | -60.36% | -39.82% | -20.54% |
Max Drawdown (10Y)Largest decline over 10 years | — | -39.82% | — |
Current DrawdownCurrent decline from peak | -61.31% | 0.00% | -61.31% |
Average DrawdownAverage peak-to-trough decline | -43.20% | -21.14% | -22.06% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 15.98% | 3.12% | +12.86% |
Volatility
EDOC vs. IBB - Volatility Comparison
Global X Telemedicine & Digital Health ETF (EDOC) and iShares Nasdaq Biotechnology ETF (IBB) have volatilities of 7.26% and 6.95%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| EDOC | IBB | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.26% | 6.95% | +0.31% |
Volatility (6M)Calculated over the trailing 6-month period | 16.63% | 15.98% | +0.65% |
Volatility (1Y)Calculated over the trailing 1-year period | 22.43% | 20.34% | +2.09% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 26.46% | 22.03% | +4.43% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 26.28% | 23.17% | +3.11% |
EDOC vs. IBB - Expense Ratio Comparison
EDOC has a 0.68% expense ratio, which is higher than IBB's 0.47% expense ratio.
Dividends
EDOC vs. IBB - Dividend Comparison
EDOC's dividend yield for the trailing twelve months is around 0.37%, more than IBB's 0.23% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EDOC Global X Telemedicine & Digital Health ETF | 0.37% | 0.33% | 0.00% | 0.00% | 0.00% | 0.00% | 0.03% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
IBB iShares Nasdaq Biotechnology ETF | 0.23% | 0.23% | 0.29% | 0.26% | 0.31% | 0.21% | 0.21% | 0.33% | 0.20% | 0.30% | 0.19% | 0.03% |
Frequently Asked Questions
EDOC and IBB have a correlation of 0.54, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
EDOC has higher volatility (7.26%) compared to IBB (6.95%). In terms of maximum drawdown, EDOC dropped -65.76% vs IBB's -62.85%.
On 5-year performance, IBB leads with 2.21% vs -14.64% for EDOC. On fees, IBB is cheaper at 0.47% per year. On volatility, IBB has been the lower-risk option at 6.95%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 5-year period, IBB has performed better with a 2.21% return vs -14.64%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
IBB is cheaper with a 0.47% expense ratio, compared with 0.68% for EDOC.
EDOC has the higher dividend yield at 0.37%, compared with 0.23% for IBB.
EDOC tracks Solactive Telemedicine & Digital Health Index- TR Net, while IBB tracks NASDAQ Biotechnology Index. They also come from different issuers: Global X and iShares. Their fees differ too: 0.68% for EDOC and 0.47% for IBB.
IBB currently has the higher Sharpe Ratio (2.12 vs -0.73), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for EDOC and IBB
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer